184 related articles for article (PubMed ID: 9113951)
1. Are beta-adrenergic bronchodilators safe?
Eggleston PA
Pediatrics; 1997 May; 99(5):729-30. PubMed ID: 9113951
[No Abstract] [Full Text] [Related]
2. Tiotropium step-up therapy in asthma.
Miller DR; Chetty M; Currie GP
N Engl J Med; 2011 Feb; 364(6):578; author reply 578-9. PubMed ID: 21306256
[No Abstract] [Full Text] [Related]
3. Salmeterol and inhaled corticosteroids in patients with persistent asthma.
Fowler SJ; Lipworth BJ
JAMA; 2001 Dec; 286(24):3076-7; author reply 3077-8. PubMed ID: 11754665
[No Abstract] [Full Text] [Related]
4. Salmeterol and inhaled corticosteroids in patients with persistent asthma.
Miller FG; Shorr AF
JAMA; 2001 Dec; 286(24):3075-6; author reply 3077-8. PubMed ID: 11754663
[No Abstract] [Full Text] [Related]
5. Salmeterol and inhaled corticosteroids in patients with persistent asthma.
Friedman Ross L
JAMA; 2001 Dec; 286(24):3076; author reply 3077-8. PubMed ID: 11754664
[No Abstract] [Full Text] [Related]
6. Salmeterol and inhaled corticosteroids in patients with persistent asthma.
Botkin JR; Clayton E; Nelson R; Wilfond B; Munger MA
JAMA; 2001 Dec; 286(24):3075; author reply 3077-8. PubMed ID: 11754662
[No Abstract] [Full Text] [Related]
7. Loss of bronchoprotection with salmeterol.
D'Urzo AD
Chest; 1996 Jul; 110(1):306. PubMed ID: 8681659
[No Abstract] [Full Text] [Related]
8. Salmeterol xinafoate in asthma.
Palmer JB; Oxford JM
JAMA; 1994 Nov 23-30; 272(20):1575-6. PubMed ID: 7966861
[No Abstract] [Full Text] [Related]
9. The pathobiologic implications for treatment. Old and new strategies in the treatment of chronic asthma.
Horiuchi T; Castro M
Clin Chest Med; 2000 Jun; 21(2):381-95, x. PubMed ID: 10907595
[TBL] [Abstract][Full Text] [Related]
10. Bronchodilator treatment in asthma. Increase in deaths during salmeterol treatment unexplained.
Sears MR; Taylor DR
BMJ; 1993 Jun; 306(6892):1610-1. PubMed ID: 8101115
[No Abstract] [Full Text] [Related]
11. Bronchodilator treatment in asthma. Manufacturers underestimate mortality from asthma.
Inman WH
BMJ; 1993 Jun; 306(6892):1610; author reply 1611. PubMed ID: 8101116
[No Abstract] [Full Text] [Related]
12. Bronchodilator treatment in asthma. Regular treatment with beta agonists remains unevaluated.
Crompton GK
BMJ; 1993 Jun; 306(6892):1610; author reply 1611. PubMed ID: 8101117
[No Abstract] [Full Text] [Related]
13. A word of caution regarding a new long-acting bronchodilator.
Bone RC
JAMA; 1994 May; 271(18):1447-8. PubMed ID: 7909854
[No Abstract] [Full Text] [Related]
14. Salmeterol xinafoate vs albuterol in asthma: was race a factor?
Olopade CO
JAMA; 1994 Nov 23-30; 272(20):1576. PubMed ID: 7966862
[No Abstract] [Full Text] [Related]
15. Bronchodilator treatment in asthma. Study too small to detect increase in deaths.
Bunney R
BMJ; 1993 Jun; 306(6892):1610; author reply 1611. PubMed ID: 8101118
[No Abstract] [Full Text] [Related]
16. Is the result of methacholine challenge accurate for assessing the bronchoprotective effects of long-acting beta-adrenergic bronchodilators?
Bumbacea D; Diot P; Lamarie E
Chest; 1996 Jul; 110(1):305-6. PubMed ID: 8681658
[No Abstract] [Full Text] [Related]
17. Prior use of long-acting beta-agonists: friend or foe in the emergency department?
Peters SP; Fish JE
Am J Med; 1999 Sep; 107(3):283-5. PubMed ID: 10492323
[No Abstract] [Full Text] [Related]
18. Long-acting beta agonists in asthma therapy.
Rissmiller RW; Larj MJ; Peters SP
Curr Allergy Asthma Rep; 2004 Mar; 4(2):91-2. PubMed ID: 14769255
[No Abstract] [Full Text] [Related]
19. Bronchodilating effect of formoterol but not of salmeterol in two asthmatic patients.
Noppen M; Vincken W
Respiration; 2000; 67(1):112-3. PubMed ID: 10705276
[No Abstract] [Full Text] [Related]
20. [Serevent in the treatment of moderate bronchial asthma].
Panghea P; Voicu G; Filip G; Arghir O; Floca L; Acasandri E; Mihai D
Pneumoftiziologia; 1996; 45(3-4):145-8. PubMed ID: 9221040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
